Trackinsight Enterprise, a unified platform for institutional ETF research, analytics, and compliance, is now live. Explore Trackinsight Enterprise →

Help us improve your experience. Please confirm your investor type:

ETF What's Up

Don’t Miss a Move in the ETF Market

Sign up and keep track of everything that moved the ETF industry this week. From new launches to regulatory shifts across the Atlantic.

›ETF Issuers›Mirae Asset Global Investments›364970

364970

Mirae Asset TIGER BIO TOP10 ETF

Passive ETF Equity

Not rated

The 364970 Exchange Traded Fund (ETF) is provided by Mirae Asset Global Investments. It is built to track an index: KRX Bio TOP 10 Index. The 364970 ETF provides physical exposure, so by buying it you actually own parts of all the 10 underlying holdings. This share class generates a stream of income by distributing dividends.

₩7,320

-₩100 (-1.35%) today

12:00 AM 09/02/26 Closed

1D price range

₩7,240₩7,600

52W price range

₩6,070₩9,765

YTD Perf.

-16.85%

YTD Flows

Annualized volatility

Fund AuM

€170M

Share class AuM

€170M

TTM Yield

Tracking Error

Tracking Difference

Characteristics

ISIN

KR7364970004

TER

0.42%

Inception date

10/7/2020

Issuer

Mirae Asset Global Investments

Benchmark

KRX Bio TOP 10 Index

Replication method

Dividend policy

Distributing

Compare similar ETFs

ETF Name	1w perf.
266420 Samsung KODEX Healthcare ETF	-2.05%
143860 Mirae Asset TIGER HEALTH CARE ETF	-2.08%
253280 RISE Healthcare ETF	-1.86%
227540 Mirae Asset TIGER 200 HEALTH CARE ETF	-1.07%

API

PerformanceDec 30, 2025 - Sep 1, 2026

Flows

Join for free to unlock

Sector exposures

Data as of 07/31/26

Healthcare

96.74%

Industrials

3.07%

Unavailable

0.19%

Latest 364970 news

No content available for this fund

FAQ about 364970

364970 is a Passive ETF. This ETF provides exposure to South Korean Equities.

364970 tracks the KRX Bio TOP 10 Index - KRW, through a optimized sampling replication method.

364970 carries a total expense ratio (TER) of 0.42%, indicating the annual cost for holding the fund.

364970 was introduced to the market on October 7, 2020. It trades on South Korea

Mirae Asset TIGER BIO TOP10 ETF, 364970, is provided by Mirae Asset Global Investments. Learn more about Mirae Asset Global Investments here.

364970 oversees €170M in assets as of September 1, 2026.

364970 follows a distributing dividend policy, meaning it pays out income to investors. As of September 1, 2026, its 12-month trailing yield was 0.61%.

As of July 31, 2026, 364970 has significant geographic allocations in Republic of Korea.

As of July 31, 2026, 364970 focuses largely on Healthcare and Industrials.

As of July 31, 2026, 364970 holds 10 positions in its portfolio, with 99.81% of assets concentrated in its top 15 holdings.

As of July 31, 2026, 364970 top three holdings include Celltrion, Inc., SAMSUNG BIOLOGICS Co., Ltd. and Alteogen, Inc..

The base currency of 364970 is KRW.

Top 10 holdings

Data as of 07/31/26

Celltrion, Inc.

29.19%

SAMSUNG BIOLOGICS Co., Ltd.

28.09%

Alteogen, Inc.

25.44%

Yuhan Corp.

3.76%

HLB Co., Ltd.

3.07%

ABL Bio, Inc.

2.37%

Peptron, Inc.

2.34%

LigaChem Biosciences, Inc.

1.91%

SK Biopharmaceuticals Co., Ltd.

1.87%

Samsung Epis Holdings Co., Ltd.

1.77%

Essentials

A forever free toolbox for fund selection, analysis, research, and ETF portfolio construction.

Essential free account includes:

More fund data
Compare up to 3 funds
More screener filters
Edit screener columns from 100+ metrics
Watchlists for saving your research
Portfolio construction and analysis
Personal dashboard for live monitoring

About Trackinsight

Since our founding in 2016, we have been at the forefront of the industry, delivering accessible, comprehensive, and reliable tools to support the evolving needs of investors.

Over the past decade, Trackinsight has expanded its operations across six countries, serving thousands of professional investors. We’ve consistently innovated to provide cutting-edge solutions that meet the changing demands of the ETF market.

In 2024, Kepler Cheuvreux, a leading independent European financial services firm, acquired a majority stake in Trackinsight, becoming the company's principal shareholder.

This strategic partnership solidifies Trackinsight's position as a premier provider of ETF selection and analysis tools, while strengthening Kepler Cheuvreux’s commitment to becoming a leading player in the ETF sector.

Together, we are committed to offering advanced services that empower professional investors, advisors, institutions, and issuers. This new step enables us to deliver even more comprehensive and innovative technological solutions, driving ETF investing to new heights.

More about Trackinsight

Don’t Miss a Move in the ETF Market

Mirae Asset TIGER BIO TOP10 ETF

FAQ about 364970

Essentials

About Trackinsight

ETF TOOLS

PLATFORM

ETF NEWS & RESEARCH

PROFESSIONAL SOLUTIONS

SOLUTIONS FOR

CONTACT US